Clinical Trials Logo

Artificial Intelligence clinical trials

View clinical trials related to Artificial Intelligence.

Filter by:
  • Recruiting  
  • Page 1 ·  Next »

NCT ID: NCT06458452 Recruiting - Clinical trials for Artificial Intelligence

Enhancing Immersion in Virtual Reality Based Advanced Life Support Training

Start date: May 31, 2024
Phase: N/A
Study type: Interventional

Virtual Reality based training modulues have become a part of simulation based medical education and are nowadays used for undergraduate and postgraduate level training of healthcare professionals.In parallel to the advancements in Artificial Intelligence technology voice regotnition has the potential to be used as an interfeace during game play .The aim of this study is whether game interface with Artificial Intelligence based voice regognition may elevate the level of immersion during the use of Virtual Reality based serious gaming for Advanced Cardiac Life Support Training.

NCT ID: NCT06448897 Recruiting - Cervical Cancer Clinical Trials

Development of an Imaging Prediction Model for Pelvic Lymph Node Metastasis of Cervical Cancer Using Artificial Intelligence Techniques.

Start date: February 1, 2024
Phase:
Study type: Observational

This study is a retrospective exploratory trial conducted at a single center, aiming to develop and validate a preoperative lymphatic metastasis model for cervical cancer using artificial intelligence deep learning. The model is trained using preoperative imaging and postoperative pathological findings of cervical cancer patients, with the goal of enhancing the accuracy of lymphatic metastasis prediction through preoperative imaging and offering insights for treatment decisions.

NCT ID: NCT06383546 Recruiting - Clinical trials for Artificial Intelligence

Artificial Intelligence-enabled ECG Detection of Congenital Heart Disease in Children: a Novel Diagnostic Tool

AI-ECG-CHD
Start date: January 1, 2024
Phase:
Study type: Observational

Congenital heart disease (CHD) is the most common congenital disease in children. The early detection, diagnosis and treatment of CHD in children is of great significance to improve the prognosis and reduce the mortality of children, but the current screening methods have limitations. Electrocardiogram (ECG), as an economical and rapid means of heart disease detection, has a very important value in the auxiliary diagnosis of CHD.Big data and deep learning technologies in artificial intelligence (AI) have shown great potential in the medical field. The advent of the big data era provides rich data resources for the in-depth study of CHD ECG signals in children. The development of deep learning technology, especially the breakthrough in the field of image recognition, provides a strong technical support for the intelligent analysis of electrocardiogram. The particularity of children electrocardiogram requires the development of a special algorithm model. At present, the research on the application of deep learning models to identify children's electrocardiograms is limited, and the training and verification from large data sets are lacking. Based on the Chinese Congenital Heart Disease Collaborative Research Network, this project aims to integrate data and deep learning technology to develop a set of intelligent electrocardiogram assisted diagnosis system (CHD-ECG AI system) suitable for children with CHD, so as to improve the early detection rate of CHD and improve the efficiency of congenital heart disease screening.

NCT ID: NCT06362330 Recruiting - Clinical trials for Artificial Intelligence

Multi-parametric MRI in Patients of Bladder Cancer

Start date: July 1, 2021
Phase:
Study type: Observational

Accurate preoperative detection of muscle-invasive bladder cancer remains a clinical challenge. The investigators aimed to develop and validate a knowledge-guided causal diagnostic network for the detection of muscle-invasive bladder cancer with multiparametric magnetic resonance imaging(MRI).

NCT ID: NCT06345105 Recruiting - Clinical trials for Artificial Intelligence

Real Time Effective Withdrawal Time and Adenoma Detection Rate

Start date: April 1, 2024
Phase:
Study type: Observational

The goal of this observational study is to assess the correlation between the artificial intelligence (AI) derived effective withdrawal time (EWT) during colonoscopy and endoscopists' baseline adenoma detection rate (ADR). The association between the AI derived EWT with ADR during the prospective colonoscopy series would also be determined. The colonoscopy video of participants will be monitored by the AI

NCT ID: NCT06321328 Recruiting - Clinical trials for Artificial Intelligence

Success of ChatGPT in Determining the Need for Postoperative Intensive Care

Start date: March 16, 2024
Phase:
Study type: Observational [Patient Registry]

This is a prospective, observational study to be conducted at Sağlık Bilimleri University Istanbul Kanuni Sultan Süleyman Training and Research Hospital and Başakşehir Çam and Sakura City Hospital. The study aims to record various preoperative and postoperative data of patients who have undergone surgeries, specifically those with ASA scores of III and IV or those indicated to potentially need postoperative intensive care. Data points include patient demographics, type of surgery, ASA score, comorbidities, lab and imaging findings, and both actual and ChatGPT version 4 predicted outcomes regarding postoperative intensive care needs, anesthesia methods, duration of stay in intensive care and the hospital, and 30-day mortality rates. ChatGPT version 4's predictions will be compared with actual outcomes and anesthesiologist decisions.

NCT ID: NCT06307197 Recruiting - Dementia Clinical Trials

HAAL: HeAlthy Ageing Eco-system for peopLe With Dementia

HAAL
Start date: October 2, 2023
Phase: N/A
Study type: Interventional

HAAL project aims to test several technological devices in order to improve the quality of life of older people with dementia and their informal and formal caregiver.

NCT ID: NCT06286267 Recruiting - Clinical trials for Artificial Intelligence

AI-Assisted System for Accurate Diagnosis and Prognosis of Breast Phyllodes Tumors

Start date: March 1, 2023
Phase:
Study type: Observational

Breast phyllodes tumor (PT) is a rare fibroepithelial tumor, accounting for 1% to 3% of all breast tumors, categorized by the WHO into benign, borderline, and malignant, based on histopathology features such as tumor border, stromal cellularity, stromal atypia, mitotic activity and stromal overgrowth. Malignant PTs account for 18%-25%, with high local recurrence (up to 65%) and distant metastasis rates (16%-25%). Benign PT could progress to malignancy after multiple recurrences. Therefore, Early, accurate diagnosis and identification of therapeutic targets are crucial for improving outcomes and survival rates. In recent years, there has been growing interest in the application of artificial intelligence (AI) in medical diagnostics. AI can integrate clinical information, histopathological images, and multi-omics data to assist in pathological and clinical diagnosis, prognosis prediction, and molecular profiling.AI has shown promising results in various areas, including the diagnosis of different cancers such as colorectal cancer, breast cancer, and prostate cancer. However, PT differs from breast cancer in diagnosis and treatment approach. Therefore, establishing an AI-based system for the precise diagnosis and prognosis assessment of PT is crucial for personalized medicine. The research team, led by Dr. Nie Yan, is one of the few in Guangdong Province and even nationally, specializing in PT research. Their team has been conducting research on the malignant progression, metastasis mechanisms, and molecular markers for PT. The team has identified key mechanisms, such as fibroblast-to-myofibroblast differentiation, and the role of tumor-associated macrophages in promoting this differentiation. They have also identified molecular markers, including miR-21, α-SMA, CCL18, and CCL5, which are more accurate in predicting tumor recurrence risk compared to traditional histopathological grading. The project has collected high-quality data from nearly a thousand breast PT patients, including imaging, histopathology, and survival data, and has performed transcriptome gene sequencing on tissue samples. They aim to build a comprehensive multi-omics database for breast PT and create an AI-based model for early diagnosis and prognosis prediction. This research has the potential to improve the diagnosis and treatment of breast PT, address the disparities in breast PT care across different regions in China, and contribute to the development of new therapeutic targets.

NCT ID: NCT06285084 Recruiting - Clinical trials for Artificial Intelligence

Deep Learning ECG Evaluation and Clinical Assessment for Competitive Sport Eligibility

VALETUDO
Start date: February 2, 2024
Phase:
Study type: Observational

The goal of this observationl study is to evaluate the possibility of building a Deep Learning (DL) model capable of analyzing electrocardiographic traces of athletes and providing information in the form of a probability stratification of cardiovascular disease. Researchers will enroll a training cohort of 455 participants, evaluated following standard clinical practice for eligibility in competitive sports. The response of the clinical evaluation and ECG traces will be recorded to build a DL model. Researchers will subsequently enroll a validation cohort of 76 participants. ECG traces will be analyzed to evaluate the accuracy of the model to discriminate participants cleared for sports eligibility versus participants who need further medical tests

NCT ID: NCT06255808 Recruiting - Breast Cancer Clinical Trials

Development of Assist Tool for Breast Examination Using the Principle of Ultrasonic Sensor

Start date: October 5, 2022
Phase:
Study type: Observational

The accuracy of breast examinations and ultrasonography performed clinically to detect breast mass varies greatly depending on the physician's skill level, and the accuracy of breast examinations by non-experts is particularly low. In this study, we aimed to validate whether the concurrent use of ultrasound sensor technology is an efficient strategy for the purpose of improving the sensitivity of detecting breast masses through breast examination.